LIVE DAY 2 ✦ Oct. 13Thursday, 13 October 2022 - EDT

7:30am - 8:15am45 mins

Registration and Breakfast - Exhibit Area - Atrium

General Session

8:15am - 8:30am15 mins

General Session

Chairperson's Opening Remarks

Katherine Chaurette - Senior Vice President, Healthcare Law and Compliance, Blueprint Medicines

8:30am - 9:10am40 mins

General Session

State of the Industry: Drug Pricing and Managed Care Programs in the US - from the Payer Perspective

9:10am - 9:50am40 mins

General Session

Congressional Insights Keynote: Proposed Legislation and Policy Updates from the Senate Committee on Finance

Anna Kaltenboeck - Senior Health Advisor, Senate Committee on Finance, Chairman Ron Wyden (D-Ore.)

9:50am - 10:30am40 mins

General Session

Navigating PBMs and Vertically Integrated Customers

Rujul Desai - Of Counsel, Covington & Burling LLP

10:30am - 11:00am30 mins

General Session

Morning Networking and Refreshment Break - Exhibit Area - Atrium

11:00am - 11:30am30 mins

General Session

Presentation Title TBD

Alice Valder Curran - Partner, Hogan Lovells US LLP

11:30am - 12:10pm40 mins

General Session

Multiple Best Price Strategies to Operationalize the Value-Based Purchasing Final Rule

Jeff Baab - Vice President, Operational Consulting, IntegriChain
John Gould - Partner, Arnold & Porter

12:10pm - 1:00pm50 mins

General Session

Ask the Attorney's: What Keeps Them Up at Night?

Michael Kurland - Vice President, Revenue Management & Compliance, EVERSANA
Christopher Schott - Partner, Latham & Watkins
Stephanie Trunk - Partner, ArentFox Schiff
John Shakow - Partner, King & Spalding

1:00pm - 2:10pm70 mins

General Session

Networking Lunch and Visit the Exhibit Hall

Track Sessions

2:10pm - 2:15pm5 mins

Track A: Implications of Recent Rules and Proposed Regulations

Chairperson's Remarks

2:10pm - 2:15pm5 mins

Track B: 30 Year Anniversary of 340B - Policy, Reform and Operationalizing the Program

Chairperson's Remarks

2:10pm - 2:15pm5 mins

Track C: Practical Strategies for Emerging, Small, and Mid-Size Companies

Chairperson's Remarks

2:15pm - 3:00pm45 mins

Track A: Implications of Recent Rules and Proposed Regulations

AMP Cap Removal: The Who, What, How

Jesse Mendelsohn - Vice President, Centers of Excellence, Model N
Mohammed Khan - Senior Manager, Deloitte & Touche
Brian McCartney - Senior Director, Market Access Policy & Government Reporting, AstraZeneca

2:15pm - 3:00pm45 mins

Track B: 30 Year Anniversary of 340B - Policy, Reform and Operationalizing the Program

Panel: 340B Thought Leadership - What's New and What's Next

Katheryne Richardson, PharmD - Executive Director and Head US 340B Strategy, Bristol Myers Squibb
Tess Morgan - Senior Manager, Product Diversion and Program Integrity, Pfizer
Katy Lees - Director of 340B Policy and Business Strategy, University of Rochester Medicine

2:15pm - 2:55pm40 mins

Track C: Practical Strategies for Emerging, Small, and Mid-Size Companies

Roadmap to a successful product launch

Walt Worsham - Managing Director, Federal Compliance Solutions LLC
Felecia Manning - Director, Managed Markets Contracts & Government Pricing, United Therapeutics Corporation
Rick Moore - Managing Partner, Federal Compliance Solutions LLC

2:55pm - 3:40pm45 mins

Track C: Practical Strategies for Emerging, Small, and Mid-Size Companies

Acquisitions and Divestitures for Emerging, Small and Mid-Sized Pharma

Dana Collins - Director, Helio Health Group
Matthew Fornataro - Partner, Arnold & Porter
Melody Hamel - Senior Operations Counsel, Viatris

3:00pm - 3:40pm40 mins

Track A: Implications of Recent Rules and Proposed Regulations

Bona Fide Service Fees and Fair Market Value Updates and Strategies

Nick Lynch, CFE - Partner, Federal Compliance Solutions LLC

3:00pm - 3:40pm40 mins

Track B: 30 Year Anniversary of 340B - Policy, Reform and Operationalizing the Program

340B Litigation Updates

William Sarraille - Partner, Sidley Austin LLP

3:40pm - 4:10pm30 mins

Track A: Implications of Recent Rules and Proposed Regulations

Afternoon Networking Break

3:40pm - 4:10pm30 mins

Track B: 30 Year Anniversary of 340B - Policy, Reform and Operationalizing the Program

Afternoon Networking Break

3:40pm - 4:10pm30 mins

Track C: Practical Strategies for Emerging, Small, and Mid-Size Companies

Afternoon Networking Break

4:10pm - 4:50pm40 mins

Track A: Implications of Recent Rules and Proposed Regulations

Line Extensions: The Operational Nightmare

Ruth Nunez - Senior Manager, US Government Pricing, Pfizer
Shrutej Patel - Director, Government Reporting, Novartis

4:10pm - 4:50pm40 mins

Track B: 30 Year Anniversary of 340B - Policy, Reform and Operationalizing the Program

State Legislation Review: 340B

4:10pm - 4:50pm40 mins

Track C: Practical Strategies for Emerging, Small, and Mid-Size Companies

Panel: Pricing Committee Development and Refresh

Tom Evegan - Principal, Strategy & Management Consulting, RSM US LLP
Rosalind Davis - Director, Government Pricing & Contracts, Vifor Pharma, Inc.
Lisa Kiniklis - Senior Director, Market Access Operations, Contracting and Pricing, Deciphera Pharmaceuticals
Marcella Lynch - Director, Forecasting and Pricing - Market Access, Rare Diseases, Chiesi USA, Inc.

4:50pm - 5:35pm45 mins

Track A: Implications of Recent Rules and Proposed Regulations

The Future of Drug Pricing Demonstration Programs

Margaux Hall - Partner, Ropes & Gray LLP
Stephanie Webster - Partner, Ropes & Gray
David Ault - Counsel, Ropes & Gray

4:50pm - 5:35pm45 mins

Track B: 30 Year Anniversary of 340B - Policy, Reform and Operationalizing the Program

Panel: The Dreaded Duplicate Discounts - Collaborating in the New Hybrid Working Landscape

4:50pm - 5:35pm45 mins

Track C: Practical Strategies for Emerging, Small, and Mid-Size Companies

Panel: Best Practices for Accurate Inputs into Government Pricing

Scott Hoffman - Head of Client Services, Woven Data
Megan Falkowski - Director, Government Pricing & Government Contracting Policy, Pfizer Inc
Stephanie Kupski - Director, U.S. Pricing & Government Reporting, CSL Behring

5:35pm - 6:35pm60 mins

Evening Reception and Visit the Exhibit Hall